Literature DB >> 2743713

Micro-ELISA for the quantitation of human urinary and serum retinol-binding protein.

T Jensen1, M Deckert, A Dawnay, B Feldt-Rasmussen.   

Abstract

A highly sensitive enzyme linked immunoadsorbent assay for determining retinol-binding protein in urine and serum is described. Commercially available reagents are used. The standard curve ranges from 1.2-24 micrograms/l, recovery of retinol-binding protein added to urine was 99-102% (n = 10) and dilution of urine was linear. The within-assay coefficient of variation ranged from 1.2-3.1% and the day-to-day coefficient of variation from 9.2-10.5% depending on concentration. The correlation with urinary retinol-binding protein determined by radioimmunoassay was good (n = 90, r = 0.95). In vitro experiments show that retinol-binding protein is stable in urine with pH 5.2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2743713

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  4 in total

1.  Urinary excretion of retinol-binding protein in type 1 (insulin-dependent) diabetic patients with microalbuminuria and clinical diabetic nephropathy.

Authors:  P Pontuch; T Jensen; T Deckert; P Ondrejka; M Mikulecky
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

2.  Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria.

Authors:  H J Bangstad; A Kofoed-Enevoldsen; K Dahl-Jørgensen; K F Hanssen
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

3.  Urinary excretion of retinol-binding protein in healthy children and adolescents.

Authors:  H J Bangstad; P Kierulf; P Kjaersgaard; K Mevold; K Dahl-Jørgensen
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

4.  Variability of serum concentrations of cystatin C and urinary retinol-binding protein, neutrophil gelatinase-associated lipocalin, immunoglobulin G, and C-reactive protein in dogs.

Authors:  D J X Liu; E Meyer; B J G Broeckx; S Daminet; J R Delanghe; E Stock; E Bogaerts; M Hesta; K Vanderperren
Journal:  J Vet Intern Med       Date:  2018-09-14       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.